Exploration of 4-aminopyrrolo[2,3-d]pyrimidine as antitubercular agents
- PMID: 35598185
- PMCID: PMC9124159
- DOI: 10.1007/s11030-022-10453-1
Exploration of 4-aminopyrrolo[2,3-d]pyrimidine as antitubercular agents
Abstract
Tuberculosis (TB) is one of the leading causes of death worldwide. Developing new anti-TB compounds using cost-effective processes is critical to reduce TB incidence and accomplish the End TB Strategy milestone. Herein, we describe the synthesis and structure-activity relationships of a library of thirty 7H-Pyrrolo[2,3-d]pyrimidine derivatives providing insights into the contributions of different aromatic, aryl and alkyl substitution at the C-4 position of the 7-deazapurine ring. The minimum inhibitory concentration (MIC) of the compounds against the green fluorescent protein (GFP) reporter strain of Mycobacterium tuberculosis was assayed using the standard broth microdilution method, and cell toxicity was determined using the MTT assay. Sixteen compounds displayed in vitro activity against the GFP reporter strain of Mycobacterium tuberculosis with MIC90 values of 0.488-62.5 µM. This study highlights the most potent derivative, N-(4-phenoxy phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine with a MIC90 value of 0.488 µM and was non-cytotoxic to the Vero cell line. Moreover, all the potent compounds from this series have a ClogP value less than 4 and molecular weight < 400; thus, likely to maintain drug-likeness during lead optimisation.
Keywords: 7H-pyrrolo [2,3-d] pyrimidines; Antitubercular activity; Cytotoxicity; SAR; Tuberculosis.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
References
-
- World Health Organization (2020) Global TB Rep 2020:9789241565714
-
- World Health Organization (2021) Global Tuberculosis Report 2021.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
